Medbio Acquires Polymer Conversions
Grand Rapids, Mich., September 2, 2020 – Medbio, LLC ("Medbio"), a contract manufacturer specializing in clean room injection molding of plastic components for the medical and biotechnology industries, has acquired Polymer Conversions, Inc. (“PCI”). Together these businesses create a premier medical device manufacturing company, capable of supporting the rapid growth of the company's customers. Medbio is a portfolio company of Graham Partners, a private investment firm targeting industrial technology and advanced manufacturing companies.
Headquartered in Western New York, Polymer Conversions (www.polymerconversions.com) is a full-service medical device contract manufacturer that specializes in complex thermoplastic injection molding and value-add assembly. PCI is highly complementary to the existing Medbio platform, expanding the company's geographic presence, while creating cross-selling opportunities across an attractive base of blue-chip medical device customers. The acquisition of PCI is also expected to present significant operational and commercial synergies as PCI joins Medbio. Chris Williams, Medbio CEO, stated, “I'm looking forward to partnering with the PCI team to expand Medbio's manufacturing capabilities, while reaching new customers and end markets.”
About Medbio (www.medbioinc.com)
Medbio is an ISO 13485:2016-certified medical contract manufacturer specializing in clean room injection molding, assembly, and packaging. Medbio is currently building products for the orthopedic, cardiovascular, ophthalmology, neurology, and biotechnology OEMs. Headquartered in Grand Rapids, Michigan, the company manufactures single-use, disposable products for high-growth end markets and is differentiated by its ability to serve as a one-stop-shop for outsourced manufacturing. Medbio has posted 15 years of growth, and now has multiple facilities in four geographic locations in Michigan and New York. Follow us on LinkedIn and Facebook.
# # #
(616) 245-0214 Ext. 113